This site uses cookies to collect activity data and personalize content. By continuing to navigate this site, you agree to allow us to collect information using cookies. Learn more about how we care for your data in our privacy notice.

Accept

PATH Resources

Our online catalog indexes publications, presentations, and related resources for peers in our field.

2002 Resources
2002 Resources
2002 Resources
    Date
  1. A brief on the current program, challenges with uptake, the potential impact of a reduced schedule, and the process from policy to implementation.
    Published: September 2021
    Type: Resource Page
  2. Rotavirus vaccination in Palestine has significantly reduced the burden of diarrhea among children, and the benefits were sustained through a vaccine product switch.In 2018, the Palestinian Ministry of Health (MOH) decided to switch from ROTARIX® to ROTAVAC® in their immunization program. Building on previous surveillance work, PATH worked with the Rostropovich Vishnevskaya Foundation and the MOH to study health indicators for two years following the switch to ROTAVAC in order to confirm the continued health benefits of the rotavirus immunization program. This brief presents the results of this impact analysis, which confirm the significant benefit that the rotavirus immunization program has had on reducing the disease burden caused by rotavirus in Palestine.
    Published: August 2021
    Type: Resource Page
  3. The United States is among the largest funders of global health. As part of a global organization with a footprint in 70+ countries, the PATH team in Washington, D.C. leverages technical expertise to equip decision-makers with the information and evidence needed to make smart global health policy. In particular, we work with policymakers to ensure that funding for global health matches the scale of the challenges we face around the world, and that US global health polices and strategies are evidence-informed, ambitious, accountable, and—most importantly—promote equitable access to health. This brief gives a high-level overview of PATH as an organization, our impact, and our footprint in the United States.
    Published: August 2021
    Type: Resource Page
  4. As part of the global response to the COVID-19 pandemic, there has been a proliferation of procurement options providing respiratory care equipment and related services to treat severe and critical COVID-19 patients. However, there is limited awareness of the various procurement options available to prospective buyers and how to utilize them.This summary brief highlights respiratory care equipment procurement options and organizations that play a pivotal role in financing, coordinating, and conducting such procurements. It aims to increase awareness of the various procurement options available to prospective respiratory care equipment buyers—such as public procurement entities at national and subnational levels, public and private health facilities, and nongovernmental organizations—in order to inform purchasing decisions. It also aims to strengthen coordination among the global respiratory care equipment community by increasing understanding of each organization’s offerings and capabilities.
    Published: August 2021
    Type: Resource Page
  5. Glucose-6-phosphate dehydrogenase (G6PD) deficiency is a common enzyme deficiency that is prevalent in many malaria-endemic countries. G6PD-deficient individuals are susceptible to hemolysis when exposed to certain medications and food, including 8-aminoquinoline drugs (primaquine and newly introduced tafenoquine) used to fully treat Plasmodium vivax malaria patients by killing the malaria parasites that lie dormant in the liver. This is known as “radical cure.” As a result, the World Health Organization (WHO) recommends conducting a G6PD test prior to initiating radical cure treatment. A simple point-of-care (POC) test for G6PD deficiency enables wide-scale radical cure treatment of patients with P. vivax malaria and accelerates elimination of the disease.
    Published: August 2021
    Type: Resource Page
Load more